Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -29.333% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
(b) COc1ccc2sc(-c3ccccc3OC)c(-c3ccc(OC)c(F)c3)c2c1
(c) COc1ccc(S(=O)(=O)Nc2ccccc2C(=O)N2CCOCC2)cc1C
(d) CCCCN(C(=O)CSc1nnc(-c2ccc(OC)cc2)n1CC)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
(e) Cc1cc([N+](=O)[O-])ccc1NC1CCCC1
Answer: e. Cc1cc([N+](=O)[O-])ccc1NC1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc([N+](=O)[O-])ccc1NC1CCCC1
Cc1cc([N+](=O)[O-])ccc1NC1CCCC1
[4-(cyclopentylamino)-5-methylphenyl]-oxido-oxoazanium